BU-NOT-SET

CONTACT US
Evolving strategies in oral solid dosage development
  • Drug product
a woman in a laboratory holding a vial
Insight
Sustainable pharmaceutical packaging
  • Sustainability
vials
Case study
Webinar | Bringing High Potent Drugs to Market
  • Drug product
  • Manufacturing
active pharmaceutical ingredient
Webinar
IVPT Strategies for reliable bioequivalence assessment
  • Drug product
  • Manufacturing
lab vials
White paper
Recipharm Advanced Bio Is Advancing Optimizing TFF for RNA
  • Biologics
  • Manufacturing
RNA
White paper
Accelerating an innovative high potency oncology therapy to market
  • Drug product
  • Manufacturing
white powder
Case study
When OSD manufacturing goes global
  • Manufacturing
white pills
Insight
Ensuring Reliable HPAPI Supply
  • Drug product
  • Manufacturing
active pharmaceutical ingredient
Insight
De-risking high-potency programmes
  • Drug product
  • Manufacturing
Recipharm lab
Insight
Insight
  • Manufacturing
What the new Drug Supply Chain Security Act (DSCSA) deadline means for the industry
Insight
  • Manufacturing
Serialisation: is the industry ready?
Insight
  • Manufacturing
Serialisation efforts must push ahead despite deadline extension
Insight
  • Drug product
Metal coordinated pharmaceuticals: a new and promising technology
Insight
  • Drug product
Optimising excipient selection
Insight
  • Manufacturing
Serialisation stragglers: Industry concern for complacency
Insight
  • Manufacturing
The race against the serialisation deadline
Insight
  • Manufacturing
Why tomorrow is too late to start your serialisation preparations
Insight
  • Manufacturing
The serialisation landscape: Challenges and opportunities for a CDMO